89 related articles for article (PubMed ID: 2179591)
1. Rotation of the anatomic regions used for insulin injections and day-to-day variability of plasma glucose in type I diabetic subjects.
Bantle JP; Weber MS; Rao SM; Chattopadhyay MK; Robertson RP
JAMA; 1990 Apr; 263(13):1802-6. PubMed ID: 2179591
[TBL] [Abstract][Full Text] [Related]
2. Reducing blood glucose variability by use of abdominal insulin injection sites.
Zehrer C; Hansen R; Bantle J
Diabetes Educ; 1990; 16(6):474-7. PubMed ID: 2076628
[TBL] [Abstract][Full Text] [Related]
3. Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects.
Bantle JP; Neal L; Frankamp LM
Diabetes Care; 1993 Dec; 16(12):1592-7. PubMed ID: 8299455
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin.
de Meijer PH; Lutterman JA
Neth J Med; 1990 Feb; 36(1-2):4-12. PubMed ID: 2179752
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial.
Tumminia A; Crimi S; Sciacca L; Buscema M; Frittitta L; Squatrito S; Vigneri R; Tomaselli L
Diabetes Metab Res Rev; 2015 Jan; 31(1):61-8. PubMed ID: 24816997
[TBL] [Abstract][Full Text] [Related]
6. Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.
Ashwell SG; Gebbie J; Home PD
Diabet Med; 2006 Aug; 23(8):879-86. PubMed ID: 16911626
[TBL] [Abstract][Full Text] [Related]
7. Rapid restoration of normoglycaemia using intravenous insulin boluses.
Dunnett JM; Steemson J; Sear JW; Turner RC; Holman RR
Diabetes Res; 1990 Dec; 15(4):151-5. PubMed ID: 2132403
[TBL] [Abstract][Full Text] [Related]
8. Lipohypertrophy: does it matter in daily life? A study using a continuous glucose monitoring system.
Overland J; Molyneaux L; Tewari S; Fatouros R; Melville P; Foote D; Wu T; Yue DK
Diabetes Obes Metab; 2009 May; 11(5):460-3. PubMed ID: 19236441
[TBL] [Abstract][Full Text] [Related]
9. Comparison of insulin levels after injection by jet stream and disposable insulin syringe.
Malone JI; Lowitt S; Grove NP; Shah SC
Diabetes Care; 1986; 9(6):637-40. PubMed ID: 3542456
[TBL] [Abstract][Full Text] [Related]
10. [Injection site for quick-acting insulin. Significance for glycemic control in basal bolus insulin regimen].
Henriksen JE; Djurhuus MS; Vaag AA; Thye-Rønn P; Knudsen DU; Nielsen OH; Beck-Nielsen H
Ugeskr Laeger; 1994 Aug; 156(35):4976-9. PubMed ID: 7992431
[TBL] [Abstract][Full Text] [Related]
11. Insulin loss at the injection site in children with type 1 diabetes mellitus.
Stewart NL; Darlow BA
Diabet Med; 1994 Oct; 11(8):802-5. PubMed ID: 7851076
[TBL] [Abstract][Full Text] [Related]
12. Comparison of insulin analogue B9AspB27Glu and soluble human insulin in insulin-treated diabetes.
Kang S; Owens DR; Vora JP; Brange J
Lancet; 1990 Feb; 335(8685):303-6. PubMed ID: 1967767
[TBL] [Abstract][Full Text] [Related]
13. A comparison of premeal subcutaneous insulin infusion and injection in type I diabetic patients under continuous basal subcutaneous insulin delivery.
Navascués I; Kerner W; Pfeiffer EF
Life Support Syst; 1985; 3(3):263-7. PubMed ID: 3900596
[TBL] [Abstract][Full Text] [Related]
14. Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single-centre, randomized controlled trial.
Heise T; Nosek L; Dellweg S; Zijlstra E; Præstmark KA; Kildegaard J; Nielsen G; Sparre T
Diabetes Obes Metab; 2014 Oct; 16(10):971-6. PubMed ID: 24720741
[TBL] [Abstract][Full Text] [Related]
15. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
[TBL] [Abstract][Full Text] [Related]
16. Automated overnight closed-loop glucose control in young children with type 1 diabetes.
Elleri D; Allen JM; Nodale M; Wilinska ME; Mangat JS; Larsen AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Technol Ther; 2011 Apr; 13(4):419-24. PubMed ID: 21355719
[TBL] [Abstract][Full Text] [Related]
17. Does an insulin pen improve the metabolic control of type 1 diabetes mellitus if added to conventional treatment?
Roos AN; Meinders AE
Neth J Med; 1989 Apr; 34(3-4):116-25. PubMed ID: 2657451
[TBL] [Abstract][Full Text] [Related]
18. Continuous subcutaneous insulin infusion is better than multiple daily insulin injections in reducing glucose variability only in type 1 diabetes with good metabolic control.
Lepore G; Corsi A; Dodesini AR; Nosari I; Trevisan R
Diabetes Care; 2010 Jun; 33(6):e81. PubMed ID: 20508226
[No Abstract] [Full Text] [Related]
19. Day-to-day variation in glycemic control in type I and type II diabetes mellitus.
Bantle JP; Laine DC
Diabetes Res; 1988 Jul; 8(3):147-9. PubMed ID: 3229076
[TBL] [Abstract][Full Text] [Related]
20. [Effect of insulin by local injection on the level of systemic blood glucose and granulation tissue formation of wound in patients with diabetic foot ulcer].
Zhang ZX; Liu XL; Lü L; Zhang L; Ji DL; Liu LH
Zhonghua Shao Shang Za Zhi; 2011 Dec; 27(6):451-5. PubMed ID: 22340792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
